Gilead Sales Beat Expectations on Strong HIV Prevention Growth
Earnings·2 articles across 2 outlets
Story updated Rewritten when the story materially grows; the wire is checked every 15 minutesAbout this data
Gilead Sciences Inc. reported sales growth that beat expectations, as its drugs for HIV prevention and treatment continued to perform well.
The company's strong performance in the HIV sector has contributed positively to its overall sales figures.
Gilead
Sources
Every quote below is verbatim from the article it is attributed to.
SourceReports the news
“Gilead Sciences Inc. reported sales growth that beat expectations, as its drugs for HIV prevention and treatment continued to perform well.”
Bloomberg — Gilead Sales Beat Expectations on Strong HIV Prevention Growth